India has extended price caps to 39 more medicines ranging from commonly used diabetes drugs to antibiotics, in the government's latest effort to improve affordability of medicines. The move......
Increased price control over branded generic medicines has affected its profitability GlaxoSmithKline (GSK) Pharmaceuticals is scouting for acquisitions in the domestic market for the first time......
The health ministry has formed a committee that is meeting for the first time on Tuesday to consider raising the number of drugs deemed essential and subject to price caps, people directly involved......
GlaxoSmithKline Consumer Healthcare on Tuesday said the multi-billion dollar global deal between parent GlaxoSmithKline Plc and Swiss drug major Novartis won't affect its business in India. The two......
The U.S. Food and Drug Administration found that a drug ingredient manufactured at a GlaxoSmithKline Plc plant in Ireland was contaminated and said the company did not take sufficient action to......